Edition:
United States

Nabriva Therapeutics PLC (NBRV.OQ)

NBRV.OQ on NASDAQ Stock Exchange Global Select Market

2.57USD
4:00pm EDT
Change (% chg)

$0.01 (+0.59%)
Prev Close
$2.56
Open
$2.56
Day's High
$2.63
Day's Low
$2.55
Volume
67,749
Avg. Vol
117,459
52-wk High
$10.58
52-wk Low
$2.34

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.85 -0.439
Mar '18 7.55 -0.361
FY 2017 Dec '17 1.12 -0.605
Sep '17 1.47 -0.791
Jun '17 1.05 -0.537
Mar '17 1.68 -5.596
FY 2016 Dec '16
Sep '16 0.97 -0.658
Jun '16 1.78 -0.570
Mar '16 1.42 -6.421
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 5 2.56 7.07 1.00 0.85
Quarter Ending Dec-18 5 1.09 1.90 0.50 0.85
Year Ending Dec-18 6 11.74 16.32 10.22 5.75
Year Ending Dec-19 6 21.53 30.40 13.27 16.09
Earnings (per share)
Quarter Ending Sep-18 5 -0.29 -0.17 -0.42 -0.41
Quarter Ending Dec-18 5 -0.31 -0.22 -0.41 -0.39
Year Ending Dec-18 6 -1.38 -1.21 -1.63 -1.78
Year Ending Dec-19 6 -1.15 -0.74 -1.43 -2.19
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 108.51 32.45
P/E High - Last 5 Yrs. -- 279.56 47.46
P/E Low - Last 5 Yrs. -- 98.19 24.76
Beta -- 0.62 0.87
Price to Sales (TTM) 15.46 109.91 6.31
Price to Book (MRQ) 1.40 12.50 3.81
Price to Tangible Book (MRQ) 2.28 18.78 5.83
Price to Cash Flow (TTM) -- 62.06 23.35
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.73
Dividend Yield - 5 Year Avg -- 0.21 1.45
Dividend 5 Year Growth Rate -- 2.59 -5.47
Payout Ratio(TTM) -- 5.87 46.56

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -19.41 176.70 8.47
Sales (TTM) vs TTM 1 Yr. Ago 82.92 93.28 6.75
Sales - 5 Yr. Growth Rate -- 24.52 7.58
EPS (MRQ) vs Qtr. 1 Yr. Ago 18.26 278.78 25.58
EPS (TTM) vs TTM 1 Yr. Ago 91.10 -- --
EPS - 5 Yr. Growth Rate -- 23.69 7.60
Capital Spending - 5 Yr. Growth Rate -- 38.72 8.44

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.61 2.19
Current Ratio (MRQ) 7.52 5.46 2.96
LT Debt to Equity (MRQ) 0.79 14.93 11.41
Total Debt to Equity (MRQ) 0.79 18.35 14.25
Interest Coverage (TTM) -135.10 -202.84 35.04

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.99 54.86
Gross Margin - 5 Yr. Avg. -- 52.63 53.37
EBITD Margin (TTM) -664.65 -- --
EBITD - 5 Yr. Avg -- -174.66 15.90
Operating Margin (TTM) -669.61 -602.22 3.68
Operating Margin - 5 Yr. Avg. -- -188.17 10.98
Pre-Tax Margin (TTM) -666.45 -599.02 3.98
Pre-Tax Margin - 5 Yr. Avg. -- -190.53 11.16
Net Profit Margin (TTM) -688.58 -594.39 0.72
Net Profit Margin - 5 Yr. Avg. -- -188.29 7.49
Effective Tax Rate (TTM) -- 11.59 20.36
Effective Tax Rate - 5 Yr. Avg. -- 19.14 24.27

Efficiency

  Company industry sector
Revenue/Employee (TTM) 124,864 5,161,374 703,739,345
Net Income/Employee (TTM) -859,784 -5,875,094 81,128,873
Receivable Turnover (TTM) 1.42 5.34 5.02
Inventory Turnover (TTM) -- 2.04 3.61
Asset Turnover (TTM) 0.14 0.38 0.81

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -98.16 0.84 9.67
Return on Assets - 5 Yr. Avg. -- 2.59 10.83
Return on Investment (TTM) -120.67 1.61 12.63
Return on Investment - 5 Yr. Avg. -- 2.06 13.94
Return on Equity (TTM) -121.82 0.35 14.80
Return on Equity - 5 Yr. Avg. -- -2.36 15.32
  1 Year 3 Year 5 Year
Sales % -17.94 -- --
EPS (TTM) % 90.25 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Nabriva Therapeutics PLC

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -2.48 -3.87 43 91
13 Week -40.30 -43.22 9 69
26 Week -52.60 -55.66 11 49
52 Week -71.20 -75.17 7 87
YTD -57.27 -60.67 10 83
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 57.09%
# of Holders: 58
Total Shares Held: 37,957,508
3 Mo. Net Change: 7,674,047
# New Positions: 9
# Closed Positions: 13
# Increased Positions: 32
# Reduced Positions: 26
# Net Buyers: 6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.